Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWRES.L Regulatory News (WRES)

  • There is currently no data for WRES

Credit Facility Agreement

24 Apr 2007 09:50

Caspian Holdings plc24 April 2007 Caspian Holdings Plc ("Caspian" or the "Company") 24 April 2007 Credit Facility Agreement Caspian Holdings announces that it has concluded an unsecured credit facilityagreement to raise up to £1,000,000 at a rate of 4% over LIBOR from investorsand major shareholders. The credit facility will be drawn down in two tranches: (i) the first tranche of £700,000 will be drawn down on 24 April 2007; and (ii) the second tranche, available at the sole discretion of Caspian and for any sum up to the outstanding balance of the credit facility limit after the first drawdown, will be drawn down within 6 months of the date of the first drawdown. This second tranche is at this date uncommitted. Participating investors have been granted 25 options over ordinary shares in theCompany for every £1.00 invested in the facility as a commitment fee The optionshave an exercise price of 4 pence and expire on 31 December 2010. The loan is a short term facility to fund working capital and new projectacquisition activities. It is intended that the facility is replaced with morepermanent finance in the future following either the extension of the Zengeldylicence area and/or new project acquisition. The loan will be repaid in full onthe earlier of an equity raising or at maturity on 11 April 2009. Majorshareholders including Chairman Michael Masterman have shown their support forthe company in participating in the loan facility. Export Quota Caspian hopes to be able to restart exports in June following a temporaryinterruption to export activities. The Company has made selected domestic salesin the interim period from April 2007 and may continue to do so until exportsare resumed.. Quarterly Production Update Production for the quarter ending 31 March 2007 was 12,000 barrels. Related Party Transaction Masterman Investments Limited ("MIL"), a company related to Michael Masterman, adirector of Caspian, and of which Michael Masterman is a director and soleshareholder, is a lender participating in the Credit Facility to the amount of£200,000 and will therefore receive 5,000,000 options as a commitment fee. Theloan by MIL is therefore classified as a related party transaction for thepurposes of the AIM Rules. Accordingly the Directors (other than MichaelMasterman), having consulted with Grant Thornton Corporate Finance (in itscapacity as the Company's nominated adviser), confirm that they are satisfiedthat the terms of MIL's participation in the credit facility are fair andreasonable insofar as the shareholders of the Company are concerned. Following this transaction and the awarding of options, Michael Masterman willbe interested in 10,100,000 ordinary shares in the Company representing aninterest of 10.2 % in the total voting rights of the Company. In addition,Michael Masterman is interested in 7,000,000 options over ordinary shares in theCompany as follows: Stock Options Held Option Exercise Price Expiry Date 2,000,000 £0.23 4 November 2007 5,000,000 £0.04 31 December 2010 Enquiries: Caspian Holdings Plc Grant Thornton Corporate FinanceMichael Masterman Gerald BeaneyT: +44 (0) 7791 288381 T: +44 (0) 20 7383 5100 Hoodless Brennan Parkgreen CommunicationsLuke Cairns Clare Irvine / Justine HowarthT: +44 (0) 20 7538 1166 T: +44 (0) 20 7851 7480 www.caspianoil.co.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
14th Apr 20217:30 amRNSHolding(s) in Company
14th Apr 20217:00 amRNSQ1 2021 Production Report
8th Apr 202111:26 amRNSAtlas Conversion Notice & Total Voting Rights
31st Mar 202110:22 amRNSResult of General Meeting & Total Voting Rights
22nd Mar 20211:00 pmRNSAtlas Conversion Notice
17th Mar 202111:00 amRNSPrice Monitoring Extension
17th Mar 20219:05 amRNSSecond Price Monitoring Extn
17th Mar 20219:00 amRNSPrice Monitoring Extension
15th Mar 20212:06 pmRNSSecond Price Monitoring Extn
15th Mar 20212:01 pmRNSPrice Monitoring Extension
15th Mar 202112:19 pmRNSDirector/PDMR Shareholding
8th Mar 20217:00 amRNSCapital Reorganisation & Notice of General Meeting
3rd Mar 20217:21 amRNSLa Parrilla Update
10th Feb 20218:09 amRNSDirectorate Change
29th Jan 202111:05 amRNSSecond Price Monitoring Extn
29th Jan 202111:00 amRNSPrice Monitoring Extension
28th Jan 20217:00 amRNSAtlas Conversion Notice
26th Jan 20218:01 amRNSIssue of Shares to a Director and Others
25th Jan 20217:00 amRNSManagement Team Update
21st Jan 20217:00 amRNSQ4 2020 Production Report
15th Jan 20217:51 amRNSExtremadura Grant Update & Loan Facility Extension
11th Jan 20217:00 amRNS£500k Atlas Facility Drawdown & Conversion Notice
22nd Dec 20207:00 amRNSLa Parrilla Update
15th Dec 202011:21 amRNSWarrant Date Extension
7th Dec 20207:00 amRNSIssue of Equity
27th Nov 20201:05 pmRNSLa Parrilla Update - Replacement
26th Nov 20207:00 amRNSLa Parrilla Update
18th Nov 20207:00 amRNSExecutive Director and CFO Appointment
21st Oct 20207:00 amRNSQ3 Production Report
9th Oct 202011:18 amRNSIssue of Shares to Creditors
8th Oct 20207:02 amRNSBlackRock Additional US$7m Loan Facility
30th Sep 20207:00 amRNSHalf-year Report to 30 June 2020
1st Sep 20209:10 amRNSBlackRock Amendment Update
26th Aug 20209:11 amRNSAtlas Facility and La Parrilla Update
5th Aug 20208:54 amRNS£500,000 Atlas Facility Drawdown
23rd Jul 20202:05 pmRNSSecond Price Monitoring Extn
23rd Jul 20202:00 pmRNSPrice Monitoring Extension
23rd Jul 20207:00 amRNSJune 2020 Quarterly Production Report
22nd Jul 20209:19 amRNSSpanish Bank Loan Facilities
30th Jun 202011:59 amRNSResult of AGM
8th Jun 202012:58 pmRNSHolding(s) in Company
2nd Jun 20202:04 pmRNSNotice of AGM and Annual Report
1st Jun 20207:35 amRNSFinal Results
17th Apr 20208:00 amRNSMarch 2020 Quarterly Production Report
1st Apr 20202:05 pmRNSSecond Price Monitoring Extn
1st Apr 20202:00 pmRNSPrice Monitoring Extension
1st Apr 202011:06 amRNSSecond Price Monitoring Extn
1st Apr 202011:00 amRNSPrice Monitoring Extension
30th Mar 20203:26 pmRNSFinancing, La Parrilla and Spain COVID-19 Update
25th Mar 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.